stars 1 stars 2 stars 3

Axis Bio is a preclinical contract research organisation with specialist capabilities in oncology, inflammation and respiratory diseases. We offer bespoke scientific models to test novel therapeutics used in the treatment of illnesses including, but not limited to, breast cancer, lung cancer, prostate cancer, arthritis and COPD. Services range from in vitro efficacy and mechanistic studies to in vivo target engagement, with each study tailored to the unique requirements of the client. Our clients are spread across the globe and include pharmaceutical and biotech businesses, university-based research organisations and virtual/semi-virtual development companies.

Axis Bio Questions

Catherine Maguire is the Director of Operations of Axis Bio.

13 people are employed at Axis Bio.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users